title: Reconstruction using the saddle prosthesis following excision of primary and metastatic periacetabular tumors.
abstract: From 1988 to 1991, 17 patients with malignant periacetabular tumors underwent limb-sparing surgery and reconstruction using the saddle prosthesis. There were 8 patients with primary malignant lesions (Group 1), and 9 patients with metastatic or systemic tumor involving the periacetabular pelvis (Group 2). All resections included excision of the acetabulum. Patients ranged in age from 24 to 76 years (average, 59.8 years). Local control was achieved in all patients. Wide margins were obtained in all patients with primary pelvic tumors. Functional outcomes were rated as follows excellent (10), good (2), fair (1), and poor (4). Three patients, all of whom had pulmonary metastasis before surgery, died within 8 months of surgery. Of the remaining 14 patients, 5 patients died between 6 and 28 months after the index procedure. At the end of the followup period, 9 patients were still alive (6 in Group 1 and 3 in Group 2), with a followup period ranging from 15 to 62 months (average, 33.4 months). The overall results for surviving patients were 7 excellent and 2 good results, with no fair or poor results.
authors.affiliation: Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, GA 30308, USA.
authors.forename: A J
authors.initials: AJ
authors.lastname: Aboulafia
authors.forename: R
authors.initials: R
authors.lastname: Buch
authors.forename: J
authors.initials: J
authors.lastname: Mathews
authors.forename: W
authors.initials: W
authors.lastname: Li
authors.forename: M M
authors.initials: MM
authors.lastname: Malawer
mesh_terms: D000077:Acetabulum / Q000601:surgery*; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006622:Hip Prosthesis / Q000009:adverse effects / Q000295:instrumentation*; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011474:Prosthesis Design; D011475:Prosthesis Failure; D012086:Reoperation; D012509:Sarcoma / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy*; D015996:Survival Rate; D016896:Treatment Outcome